Clinical Trials Directory

Trials / Sponsors / Kadmon, a Sanofi Company

Kadmon, a Sanofi Company

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnSafety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Na
Chronic Graft Versus Host Disease
Phase 22025-06-16
TerminatedA Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR4
Solid Tumor
Phase 12023-03-06
CompletedA Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy
Immune System Disorder, Healthy Volunteers
Phase 12022-07-27
CompletedExtended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213
Chronic Graft-versus-host-disease
Phase 22022-02-23
TerminatedEfficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 22021-03-03
CompletedKD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impai
Hepatic Impairment
Phase 12019-12-11
TerminatedKD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis
System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis
Phase 22019-06-26
TerminatedEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Chronic Graft-versus-host-disease
Phase 22018-10-11
CompletedStudy of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
Autosomal Dominant Polycystic Kidney, ADPKD
Phase 22017-10-12
CompletedA Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host
Graft vs Host Disease
Phase 22016-09-15
CompletedA Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjec
Immune System Disorder (Healthy Volunteer)
Phase 12014-03-28
CompletedA Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopaus
Immune System Disorder (Healthy Volunteer)
Phase 12013-11-21
CompletedA Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidn
Polycystic Kidney, Autosomal Dominant
Phase 1 / Phase 22012-10-11
CompletedA Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects
Immune System Disorder (Healthy Volunteer)
Phase 12009-09-21